• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Cyclin-dependent kinase 1 (CDK1)

Amino acids 1-297 form the expressed segment for recombinant Human CDK1. This CDK1 protein is expected to have a theoretical molecular weight of 38.1 kDa. Expression of this CDK1 protein is conducted in e.coli. The N-terminal 6xHis tag was smoothly integrated into the coding gene of CDK1, which enables a simple process of detecting and purifying the CDK1 recombinant protein in the following steps.Cyclin-dependent kinase 1 (CDK1) is a pivotal protein kinase that governs the progression of the cell cycle, particularly during the transition from the G2 to M phase. Operating in concert with its regulatory partner, cyclin B, CDK1 orchestrates key cellular events such as nuclear envelope breakdown, chromosome condensation, and spindle assembly, crucial for successful cell division. The precise regulation of CDK1 activity is imperative for maintaining proper cell cycle dynamics. In the G1 phase, CDK1 remains inactive, and its activation is contingent on cyclin B binding as cells advance through the cell cycle. Dysregulation of CDK1 has been implicated in various diseases, notably cancer, underscoring its significance as a therapeutic target. Researchers are exploring CDK1 inhibitors for their potential to disrupt aberrant cell cycle progression, shedding light on novel strategies for cancer treatment.

ACP02396

Amino acids 1-297 form the expressed segment for recombinant Human CDK1. This CDK1 protein is expected to have a theoretical molecular weight of 38.1 kDa. Expression of this CDK1 protein is conducted in e.coli. The N-terminal 6xHis tag was smoothly integrated into the coding gene of CDK1, which enables a simple process of detecting and purifying the CDK1 recombinant protein in the following steps.Cyclin-dependent kinase 1 (CDK1) is a pivotal protein kinase that governs the progression of the cell cycle, particularly during the transition from the G2 to M phase. Operating in concert with its regulatory partner, cyclin B, CDK1 orchestrates key cellular events such as nuclear envelope breakdown, chromosome condensation, and spindle assembly, crucial for successful cell division. The precise regulation of CDK1 activity is imperative for maintaining proper cell cycle dynamics. In the G1 phase, CDK1 remains inactive, and its activation is contingent on cyclin B binding as cells advance through the cell cycle. Dysregulation of CDK1 has been implicated in various diseases, notably cancer, underscoring its significance as a therapeutic target. Researchers are exploring CDK1 inhibitors for their potential to disrupt aberrant cell cycle progression, shedding light on novel strategies for cancer treatment.

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP02396 Target NameCDK1
FormLiquid or Lyophilized powderExpression SystemE.coli
Expression Range1-297aaMol Weight38.1 kDa
Protein LengthFull lengthPurityGreater than 85% as determined by SDS-PAGE.
Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDP06493
Background Information
  • Uniprot Id

    P06493

  • Target Species

    Human

  • Target Name

    CDK1

  • Target Full Name

    Cyclin-dependent kinase 1

  • Target Function

    Plays a key role in the control of the eukaryotic cell cycle by modulating the centrosome cycle as well as mitotic onset; promotes G2-M transition, and regulates G1 progress and G1-S transition via association with multiple interphase cyclins. Required in higher cells for entry into S-phase and mitosis. Phosphorylates PARVA/actopaxin, APC, AMPH, APC, BARD1, Bcl-xL/BCL2L1, BRCA2, CALD1, CASP8, CDC7, CDC20, CDC25A, CDC25C, CC2D1A, CENPA, CSNK2 proteins/CKII, FZR1/CDH1, CDK7, CEBPB, CHAMP1, DMD/dystrophin, EEF1 proteins/EF-1, EZH2, KIF11/EG5, EGFR, FANCG, FOS, GFAP, GOLGA2/GM130, GRASP1, UBE2A/hHR6A, HIST1H1 proteins/histone H1, HMGA1, HIVEP3/KRC, LMNA, LMNB, LMNC, LBR, LATS1, MAP1B, MAP4, MARCKS, MCM2, MCM4, MKLP1, MYB, NEFH, NFIC, NPC/nuclear pore complex, PITPNM1/NIR2, NPM1, NCL, NUCKS1, NPM1/numatrin, ORC1, PRKAR2A, EEF1E1/p18, EIF3F/p47, p53/TP53, NONO/p54NRB, PAPOLA, PLEC/plectin, RB1, TPPP, UL40/R2, RAB4A, RAP1GAP, RCC1, RPS6KB1/S6K1, KHDRBS1/SAM68, ESPL1, SKI, BIRC5/survivin, STIP1, TEX14, beta-tubulins, MAPT/TAU, NEDD1, VIM/vimentin, TK1, FOXO1, RUNX1/AML1, SAMHD1, SIRT2 and RUNX2. CDK1/CDC2-cyclin-B controls pronuclear union in interphase fertilized eggs. Essential for early stages of embryonic development. During G2 and early mitosis, CDC25A/B/C-mediated dephosphorylation activates CDK1/cyclin complexes which phosphorylate several substrates that trigger at least centrosome separation, Golgi dynamics, nuclear envelope breakdown and chromosome condensation. Once chromosomes are condensed and aligned at the metaphase plate, CDK1 activity is switched off by WEE1- and PKMYT1-mediated phosphorylation to allow sister chromatid separation, chromosome decondensation, reformation of the nuclear envelope and cytokinesis. Inactivated by PKR/EIF2AK2- and WEE1-mediated phosphorylation upon DNA damage to stop cell cycle and genome replication at the G2 checkpoint thus facilitating DNA repair. Reactivated after successful DNA repair through WIP1-dependent signaling leading to CDC25A/B/C-mediated dephosphorylation and restoring cell cycle progression. In proliferating cells, CDK1-mediated FOXO1 phosphorylation at the G2-M phase represses FOXO1 interaction with 14-3-3 proteins and thereby promotes FOXO1 nuclear accumulation and transcription factor activity, leading to cell death of postmitotic neurons. The phosphorylation of beta-tubulins regulates microtubule dynamics during mitosis. NEDD1 phosphorylation promotes PLK1-mediated NEDD1 phosphorylation and subsequent targeting of the gamma-tubulin ring complex (gTuRC) to the centrosome, an important step for spindle formation. In addition, CC2D1A phosphorylation regulates CC2D1A spindle pole localization and association with SCC1/RAD21 and centriole cohesion during mitosis. The phosphorylation of Bcl-xL/BCL2L1 after prolongated G2 arrest upon DNA damage triggers apoptosis. In contrast, CASP8 phosphorylation during mitosis prevents its activation by proteolysis and subsequent apoptosis. This phosphorylation occurs in cancer cell lines, as well as in primary breast tissues and lymphocytes. EZH2 phosphorylation promotes H3K27me3 maintenance and epigenetic gene silencing. CALD1 phosphorylation promotes Schwann cell migration during peripheral nerve regeneration. CDK1-cyclin-B complex phosphorylates NCKAP5L and mediates its dissociation from centrosomes during mitosis. Regulates the amplitude of the cyclic expression of the core clock gene ARNTL/BMAL1 by phosphorylating its transcriptional repressor NR1D1, and this phosphorylation is necessary for SCF(FBXW7)-mediated ubiquitination and proteasomal degradation of NR1D1. Phosphorylates EML3 at 'Thr-881' which is essential for its interaction with HAUS augmin-like complex and TUBG1.; (Microbial infection) Acts as a receptor for hepatitis C virus (HCV) in hepatocytes and facilitates its cell entry.

  • Target Subcellular Location

    Nucleus. Cytoplasm. Mitochondrion. Cytoplasm, cytoskeleton, microtubule organizing center, centrosome. Cytoplasm, cytoskeleton, spindle. Note=Cytoplasmic during the interphase. Colocalizes with SIRT2 on centrosome during prophase and on splindle fibers during metaphase of the mitotic cell cycle. Reversibly translocated from cytoplasm to nucleus when phosphorylated before G2-M transition when associated with cyclin-B1. Accumulates in mitochondria in G2-arrested cells upon DNA-damage.

  • Target Protein Families

    Protein kinase superfamily, CMGC Ser/Thr protein kinase family, CDC2/CDKX subfamily

  • Target Tissue Specificity

    Isoform 2 is found in breast cancer tissues.

  • Target Research Area

    Cell Biology

  • Target Synonyms

    Cdc 2; Cdc2; CDC28A; CDK 1; CDK1; CDK1_HUMAN; CDKN1; CELL CYCLE CONTROLLER CDC2; Cell division control protein 2; Cell division control protein 2 homolog; Cell division cycle 2 G1 to S and G2 to M; Cell division protein kinase 1; Cell Divsion Cycle 2 Protein; Cyclin Dependent Kinase 1; Cyclin-dependent kinase 1; DKFZp686L20222; MGC111195; p34 Cdk1; p34 protein kinase; P34CDC2

  • Target Background

    The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is a catalytic subunit of the highly conserved protein kinase complex known as M-phase promoting factor (MPF), which is essential for G1/S and G2/M phase transitions of eukaryotic cell cycle. Mitotic cyclins stably associate with this protein and function as regulatory subunits. The kinase activity of this protein is controlled by cyclin accumulation and destruction through the cell cycle. The phosphorylation and dephosphorylation of this protein also play important regulatory roles in cell cycle control. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.

Inquire Recombinant Human Cyclin-dependent kinase 1 (CDK1) Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification